Insulet (PODD)
(Delayed Data from NSDQ)
$236.62 USD
-1.07 (-0.45%)
Updated Sep 20, 2024 04:00 PM ET
3-Hold of 5 3
D Value B Growth D Momentum C VGM
Industry / Sector Report
Industry : Medical - Products
Zacks Industry Rank
Top 25% (63 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.35 | 1.69 | 9.99 |
Current Quarter Estimate | 0.78 | 7.55 | 61.00 |
Year Ago Quarter Estimate | 0.71 | 4.52 | 54.84 |
Next Quarter Estimate | 1.05 | 8.31 | 63.00 |
Next Year Estimate | 3.85 | 45.15 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 10.55 | 12.40 | 15.67 |
Next Year | 26.64 | 22.20 | 11.34 |
Last 5 Years | 114.70 | 2.90 | 8.10 |
Next 5 Years | 17.60 | 15.90 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 69.79 | 4.88 |
Price/Book (MRQ) | 16.60 | 2.18 |
Price/Cash Flow (MRFY) | 62.34 | 11.77 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 21.11% | -9.36% |
Return on Equity (TTM) | 30.73% | -3.53% |
Debt to Equity (MRQ) | 1.36 | 23.08 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.